Twist Bioscience insider sold 9,242 shares for $306,353 in prior quarter
Rhea-AI Filing Summary
Twist Bioscience Corp (TWST) insider filing reports a proposed sale of 3,000 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $93,450, and an approximate sale date of 10/08/2025 on NASDAQ. The shares were acquired on 10/01/2025 via restricted stock vesting and were paid as compensation. The filer also disclosed three prior open-market sales during the past three months totaling 9,242 shares for gross proceeds of $306,353.08 (sales on 07/09/2025, 08/21/2025, and 10/06/2025). The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.
Positive
- Vested shares (3,000) were received as compensation on 10/01/2025
- Sales were executed through a registered broker (Fidelity Brokerage Services LLC) on a major exchange (NASDAQ)
Negative
- Insider sold 9,242 shares in the past three months for $306,353.08, increasing near-term share supply
- Planned sale of 3,000 vested shares on 10/08/2025 could further increase available shares
Insights
Insider sold 9,242 shares recently and plans to sell 3,000 vested shares on 10/08/2025.
The filing shows a planned sale of 3,000 shares valued at $93,450, acquired by restricted stock vesting on 10/01/2025. Recent open-market dispositions total 9,242 shares for $306,353.08, indicating the insider has been converting equity compensation to cash over the past quarter.
This pattern increases share supply from an insider in the near term and may modestly affect free‑float dynamics; monitor trading around 10/08/2025 and subsequent filings for additional disposals within the reporting window.